Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment

Helene Højsgaard Chow, Eva Rosa Petersen, Anna Olsson, Julie Hejgaard Laursen, Malene Bredahl Hansen, Annette Bang Oturai, Per Soelberg Sørensen, Helle Bach Søndergaard, Finn Sellebjerg

Fingeraftryk

Dyk ned i forskningsemnerne om 'Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Food Science